TABLE 7.
Parameter | Covariates screened |
---|---|
Relative bioavailability (RELF) | Fed status,a dose, tablet strength, sex, age, race |
Transit absorption rate (KTR) | Formulation, dose, tablet strength, sex, age, race |
Central compartment vol (V) | Sex, age, race |
Clearance (CL) | Dose, sex, age, race, smoker status |
Peripheral compartment vol (VP1) | Sex, age, race |
Fed status effect on RELF was also assessed for a difference between formulations.